223 related articles for article (PubMed ID: 23953908)
1. New developments in parenteral anticoagulation for arterial and venous thromboembolism.
van Es N; Bleker SM; Büller HR; Coppens M
Best Pract Res Clin Haematol; 2013 Jun; 26(2):203-13. PubMed ID: 23953908
[TBL] [Abstract][Full Text] [Related]
2. Anticoagulation for acute coronary syndromes: from heparin to direct thrombin inhibitors.
Lepor NE
Rev Cardiovasc Med; 2007; 8 Suppl 3():S9-17. PubMed ID: 17917621
[TBL] [Abstract][Full Text] [Related]
3. Anticoagulation in children: Making the most of little patients and little evidence.
Young G; Male C; van Ommen CH
Blood Cells Mol Dis; 2017 Sep; 67():48-53. PubMed ID: 28552476
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic evaluation of argatroban for the treatment of acute coronary syndrome.
Cruz-González I; López-Jiménez R; Perez-Rivera A; Yan BP
Expert Opin Drug Metab Toxicol; 2012 Nov; 8(11):1483-93. PubMed ID: 22970706
[TBL] [Abstract][Full Text] [Related]
5. Translational success stories: development of direct thrombin inhibitors.
Coppens M; Eikelboom JW; Gustafsson D; Weitz JI; Hirsh J
Circ Res; 2012 Sep; 111(7):920-9. PubMed ID: 22982873
[TBL] [Abstract][Full Text] [Related]
6. Parenteral anticoagulants: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
Garcia DA; Baglin TP; Weitz JI; Samama MM
Chest; 2012 Feb; 141(2 Suppl):e24S-e43S. PubMed ID: 22315264
[TBL] [Abstract][Full Text] [Related]
7. Direct thrombin inhibitors.
Lee CJ; Ansell JE
Br J Clin Pharmacol; 2011 Oct; 72(4):581-92. PubMed ID: 21241354
[TBL] [Abstract][Full Text] [Related]
8. Direct thrombin inhibitors in acute coronary syndromes: principal results of a meta-analysis based on individual patients' data.
Direct Thrombin Inhibitor Trialists' Collaborative Group
Lancet; 2002 Jan; 359(9303):294-302. PubMed ID: 11830196
[TBL] [Abstract][Full Text] [Related]
9. Heparin-Induced Thrombocytopenia: A Comprehensive Clinical Review.
Salter BS; Weiner MM; Trinh MA; Heller J; Evans AS; Adams DH; Fischer GW
J Am Coll Cardiol; 2016 May; 67(21):2519-32. PubMed ID: 27230048
[TBL] [Abstract][Full Text] [Related]
10. [Direct inhibitors of thrombin, hirudin, bivalirudin, and dabigatran etexilate].
Meddahi S; Samama MM
J Mal Vasc; 2011 Feb; 36(1):24-32. PubMed ID: 21239127
[TBL] [Abstract][Full Text] [Related]
11. Direct thrombin inhibition during percutaneous coronary intervention in patients with heparin-induced thrombocytopenia.
Lewis BE; Hursting MJ
Expert Rev Cardiovasc Ther; 2007 Jan; 5(1):57-68. PubMed ID: 17187457
[TBL] [Abstract][Full Text] [Related]
12. Bivalirudin versus unfractionated heparin during percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndrome initially treated with fondaparinux: results from an international, multicenter, randomized pilot study (SWITCH III).
Waksman R; Bertrand O; Driesman M; Gruberg L; Rossi J; Mehta S; Swymelar S; Dvir D; Xue Z; Torguson R
J Interv Cardiol; 2013 Apr; 26(2):107-13. PubMed ID: 23240743
[TBL] [Abstract][Full Text] [Related]
13. Heparin and other rapidly acting anticoagulants.
Hyers TM
Semin Vasc Surg; 2005 Sep; 18(3):130-3. PubMed ID: 16168887
[TBL] [Abstract][Full Text] [Related]
14. Parenteral anticoagulants: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
Hirsh J; Bauer KA; Donati MB; Gould M; Samama MM; Weitz JI
Chest; 2008 Jun; 133(6 Suppl):141S-159S. PubMed ID: 18574264
[TBL] [Abstract][Full Text] [Related]
15. Bivalirudin, a bivalent, thrombin specific anticoagulant as an alternative to heparin in interventional procedures as an alternative to heparin in interventional procedures.
Chew DP
Hamostaseologie; 2002 Aug; 22(3):60-6. PubMed ID: 12215763
[TBL] [Abstract][Full Text] [Related]
16. Direct thrombin inhibitors.
Kaplan KL
Expert Opin Pharmacother; 2003 May; 4(5):653-66. PubMed ID: 12739991
[TBL] [Abstract][Full Text] [Related]
17. Old and new antithrombotic drugs in neonates and infants.
Young G
Semin Fetal Neonatal Med; 2011 Dec; 16(6):349-54. PubMed ID: 21816695
[TBL] [Abstract][Full Text] [Related]
18. Direct thrombin inhibitors in cardiac disease.
Weitz JI; Bates ER
Cardiovasc Toxicol; 2003; 3(1):13-25. PubMed ID: 12668887
[TBL] [Abstract][Full Text] [Related]
19. Laboratory Monitoring of Parenteral Direct Thrombin Inhibitors.
Van Cott EM; Roberts AJ; Dager WE
Semin Thromb Hemost; 2017 Apr; 43(3):270-276. PubMed ID: 28052306
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of treatment with direct thrombin inhibitors in patients with heparin-induced thrombocytopenia.
Dang CH; Durkalski VL; Nappi JM
Pharmacotherapy; 2006 Apr; 26(4):461-8. PubMed ID: 16553503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
